8,167 Shares in CVS Health Corporation $CVS Purchased by Leo Wealth LLC

Leo Wealth LLC purchased a new position in CVS Health Corporation (NYSE:CVS) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 8,167 shares of the pharmacy operator’s stock, valued at approximately $648,000.

Other institutional investors have also recently modified their holdings of the company. Harbor Capital Advisors Inc. grew its stake in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the last quarter. Corundum Trust Company INC purchased a new stake in shares of CVS Health in the third quarter worth $29,000. Front Row Advisors LLC grew its stake in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares during the last quarter. Finally, GoalVest Advisory LLC bought a new stake in CVS Health during the 4th quarter valued at about $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CVS. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. TD Cowen restated a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Morgan Stanley raised their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Piper Sandler reduced their price objective on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research note on Tuesday, March 31st. Finally, Robert W. Baird raised their price objective on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.95.

CVS Health Stock Down 0.3%

NYSE:CVS opened at $73.24 on Tuesday. The firm has a 50-day simple moving average of $75.52 and a two-hundred day simple moving average of $77.72. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The firm has a market cap of $93.17 billion, a P/E ratio of 53.07, a P/E/G ratio of 0.77 and a beta of 0.51. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. During the same period in the previous year, the business posted $1.19 earnings per share. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. CVS Health’s payout ratio is currently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.